Give your patients the assurance of answers to their symptoms and a definitive
solution for their care. Zio’s flexible, uninterrupted cardiac monitoring helps
you find the data you need for a confident diagnosis in just a single test.
PROVIDE SUPERIOR CLINICAL SERVICE
Zio XT’s proven higher diagnostic yield over Holter allows you to provide the best clinical service for your arrhythmia patient. In fact, in a head-to-head comparison with Holter, Zio XT enabled doctors to make a meaningful change in clinical management for 28.4% of patients with atrial fibrillation.
Rosenberg, M., et al. Use of a Noninvasive Continuous Monitoring Device in the Management of Atrial Fibrillation: A Pilot Study. Pacing and Clinical Electrophysiology, 2013.
More and more payers agree: Zio is a cost-effective, high diagnostic yield, first-line monitoring solution. Give your patient the assurance of an accurate diagnosis without costly repeat tests.
3Commissioned analysis by Decision Drivers Analytics, which used 2015 Medicare fee schedules to estimate Medicare payment and diagnostic yields derived from Zio Service Data, Rothman et al. (2007); Tsang et al. (2014) & Rei el et al. (2005)
ZIO BY iRHYTHM ON CNBC NIGHTLY BUSINESS REPORT.
Video featured in the January 30, 2017 CNBC Modern Medicine article titled
"A tiny patch powering big data is changing the way we monitor heartbeats".